Harnessing Sleep/Circadian Rhythm Data as a Biomarker to Mitigate Health Risks
調査の概要
状態
条件
詳細な説明
This project will involve recruitment of 100 adolescents from primary and specialty health clinics. Participants will participate in 3 phases: screening/intake visit, sleep study, and follow-up visit.
The 1-hour screening/intake visit will be conducted at the Duke ADHD clinic at 2608 Erwin Road, Pavilion East, Suite 300, Durham, NC 27705. During the screening/intake visit, participants and their parents will complete questionnaires regarding the adolescent's psychiatric health. Participants' vitals (i.e., height, weight, resting heart rate, blood pressure) will also be assessed and recorded.
Eligible participants will enter the 7-day sleep study, during which they will be asked to wear an actigraph watch 24 hours/day, apply a EEG sleep recorder each night, and complete a daily sleep diary.
Following the final night of the sleep study, participants and parents will be asked to return for a follow-up visit and will complete questionnaires about the participants' sleep over the past week.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
North Carolina
-
Durham、North Carolina、アメリカ、27705
- Duke Child and Family Study Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Male or Female
- Between the ages of 11 years 0 months to 17 years 11 months (inclusive), at the time of parental informed consent.
- Ability to follow written and verbal instructions (English), as assessed by the PI and/or study coordinator.
- Ability to comply with all testing, requirements, study procedures, and availability for the duration of the study.
Exclusion Criteria:
- Participants who have a diagnosis of occult sleep disorders (i.e., sleep apnea, periodic leg movement syndrome)
- Participants who currently use prescribed or over-the-counter sleep aids (i.e., melatonin)
- Participants who have acute or chronic medical illnesses or medications that may interfere with sleep as determined by the research team.
- Unable to comply with study requirements or otherwise unsuitable for participation in the opinion of the principal investigator.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Adolescents
Adolescents, male or female, ages 11 - 17. Participants will complete 7 days/nights of actigraphy and sleep-based EEG and questionnaires.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Psychiatric Health - Internalizing and Externalizing Symptoms of Childhood
時間枠：1 Day
|
"Internalizing symptoms" and "Externalizing symptoms" subscales of the Child Behavior Checklist (CBCL)
|
1 Day
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acceptability of Devices - Tolerability Scale
時間枠：1 day
|
Tolerability will be assessed using the At Home PSG Tolerability Scale, developed by Dr. Lunsford-Avery (PI) and colleagues.
This scale measures comfort of devices while asleep and awake, sleep disturbances resulting from device use, and satisfaction with the devices.
|
1 day
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Jessica R Lunsford-Avery, PhD、Duke University
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。